Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Home
Stock
LRMR
LRMR News & Events
-
Add to Watchlist
Trade LRMR
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Stock Price Prediction
Technical
Valuation
Financials
Earnings
Should I Buy
News & Events
LRMR News
Larimar Therapeutics Prices Upsized Public Offering of 20 Million Shares
Feb 26 2026
NASDAQ.COM
Marriott Vacations Reports Strong Q4, Shares Surge
Feb 26 2026
Benzinga
Larimar Therapeutics Prices Upsized Public Offering of 20M Shares at $5.00 Each
Feb 26 2026
seekingalpha
Wall Street Opens Cautiously Amid China Market Concerns
Feb 26 2026
stocktwits
Larimar Therapeutics Prices $100 Million Stock Offering Following FDA Breakthrough Designation
Feb 26 2026
stocktwits
Larimar Therapeutics Prices Upsized Public Offering
Feb 26 2026
Newsfilter
Larimar Therapeutics Launches $75 Million Public Offering
Feb 25 2026
seekingalpha
Larimar Therapeutics Launches $75 Million Public Offering
Feb 25 2026
Yahoo Finance
Show More News
LRMR Events
02/25 21:10
Deal Size Increased to $100M, Priced at $4.75-$5.25 Range
The deal size was increased to $100M from $75M and priced at midpoint of $4.75-$5.25 range. JPMorgan and Guggenheim are acting as joint book running managers for the offering.
02/25 16:40
JPMorgan and Guggenheim Jointly Manage Offering
JPMorgan and Guggenheim are acting as joint book running managers for the offering.
Show More Events
LRMR Monitor News
Larimar's Nomlabofusp Receives FDA Breakthrough Therapy Designation
Feb 25 2026
Larimar Therapeutics surges amid market gains
Feb 24 2026
LRMR Earnings Analysis
No Data
People Also Watch
